Skip to main content
Fig. 3 | Breast Cancer Research

Fig. 3

From: Serum exosomal-annexin A2 is associated with African-American triple-negative breast cancer and promotes angiogenesis

Fig. 3

The expression of exo-AnxA2 levels and its association with clinicopathological features. a Scatter plot analysis of expression of serum exo-AnxA2 levels in non-cancer females (n = 68) and different grades of breast tumor patients (grade I, n = 16; grade II, n = 49; and grade III, n = 94). The data are expressed as the mean ± SEM (ns, non-significant; ****, P < 0.0001; one-way ANOVA followed by Tukey’s multiple comparison test). Kaplan-Meier survival analysis for exo-AnxA2 levels in serum samples of breast cancer patients. b Overall survival of patients with breast cancer based on serum exo-AnxA2 expression using Kaplan-Meier curves (n = 169). c Diseases-free survival of patients with breast cancer on serum exo-AnxA2 expression (n = 107). The P value was calculated using the log-rank test

Back to article page